Persistent Dystonia Associated with Buspirone
Neurol 40:1904, Boylan,K., 1990
Dystonia Gene in Ashkenazi Jewish Population is Located on Chromosome 9q32-34
Ann Neurol 27:114-120, Kramer,P.L.,et al, 1990
The Movement Disorder of Reflex Sympathetic Dystrophy
Neurol 40:57-61, Schwartzman,R.J.&Kerrigan,J., 1990
The Triumph of Linkage Analysis, Editorial
Ann Neurol 27:111-113, Rosenberg,R.N., 1990
Muscle Cramps
Arch Int Med 150:511-518, McGee,S.R., 1990
Treatment of Benign Essential Blepharospasm with Cyproheptadine
NEJM 322:778, Fasanella,R.M.&Aghajanian,G.K., 1990
Extrapyramidal Involvement in Rett's Syndrome
Neurol 40:293-295, FitzGerald,P.M.,et al, 1990
Patterns of Disease Activity in Multiple Sclerosis:Clinical and Magnetic Resonance Imaging Study
BMJ 300:631-634, Thompson,A.J.,et al, 1990
Idiopathic Cerebellar Ataxia of Late Onset:Natural History and MRI Morphology
JNNP 53:297-305, Klockgether,T.,et al, 1990
European Stroke Prevention Study
ESPS Group, Stroke 21:1122-11301990., , 1990
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
NEJM 323:148-152, Smith,P.,et al, 1990
Blood Pressure, Stroke, and Coronary Heart Disease
Lancet 335:827-838, Collins,R.,et al, 1990
Wilson's Disease, Development of Neurological Disease after Beginning Penicillamine Therapy
Arch Neurol 47:595-596, Glass,J.D.,et al, 1990
Natural History of Adult-Onset Idiopathic Torticollis
Arch Neurol 47:548-552, Jahanshahi,M.,et al, 1990
Botulinum Toxin Treatment in Spasmodic Torticollis
JNNP 53:640-643, Blacke,J.D.&Lees,A.J., 1990
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Double-Blind, Placebo-Controlled Trial of Botulinum Toxin Injections for the Treatment of Spasmodic Torticollis
Neurol 40:1213-1218, Greene,P.,et al, 1990
Swallowing Function in Patients with Spasmodic Torticollis
Neurol 40:1443-1445, Riski,J.E.,et al, 1990
Progressive Dystonia Following Resuscitation From Cardiac Arrest
Neurol 40:1458-1461, Boylan,K.B.,et al, 1990
Efficacy & Toxicity of Cyclosporine in Chronic Progressive Multiple Sclerosis:A Randomized Clinical Trial
M. S. Study Group, Ann Neurol 27:591-605, 5890., , 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Cortical-Basal Ganglionic Degeneration
Neurol 40:1203-1212, Riley,D.E.,et al, 1990
Selective Expression of Purkinje-Cell Antigens in Tumor From Pts, with Paraneoplastic Cerbellar Degeneration
NEJM 322:1844-1851, Furneaux,H.M.,et al, 1990
Autoantibody Synthesis in the Central Nervous System of Patients with Paraneoplastic Syndromes
Neurol 40:1085-1091, Furneaux,H.F.,et al, 1990
A Familial Syndrome of Dystonia, Blepharospasm, and Pigmentary Retinopathy
Neurol 40:1359-1363, Coppeto,J.R.&Lessel,S., 1990
Vitamin E for Prevention of Perinatal Intracranial Hemorrhage
Pediatrics 85:865-867, Poland,R.L., 1990
Cerebral Cortex and Brainstem Involvement in Marinesco-Sjogren Syndrome
Ann Neurol 27:448-449, Katafuchi,Y.,et al, 1990
A Quantitative Evaluation of Pontine Volume by Computed Tomography in Patients with Cerebral Degeneration
Neurol 40:1241-1245, Chida,K.,et al, 1990
Thromboembolic Complications in Atrial Fibrillation
Stroke 21:4-13, Petersen,P., 1990
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Study Group, NEJM 322:863-8681990., , 1990
Botulinum Toxin Injections for Cervical Dystonia
Neurol 40:277-280, Jankovic,J.&Schwartz,P.A., 1990
The Marinesco-Sjogren Syndrome Examined by CT, MR, and 18F-2-Fluoro-2-Deoxy-D-Glucose & PET
Arch Neurol 47:1239-1242, Bromberg,M.B.,et al, 1990
Cerebellar Atrophy Following Acute Intoxication with Phenytoin
Neurol 40:1800, Masur,H.,et al, 1990
Progressive Myoclonic Ataxia (The Ramsay Hunt Syndrome)
Arch Neurol 47:1121-1125, Marsden,C.D.,et al, 1990
Hemifacial Spasm in Rochester & Olmsten County, Minnesota, 1960-21984
Arch Neurol 47:1233-1234, Auger,R.G.&Whisnant,J.P., 1990
Dopa-Responsive Dystonia:The Spectrum of Clinical Manifestations in a Large North American Family
Neurol 40:66-69, Nygaard,T.G.,et al, 1990
Levodopa-Induced Dyskinesia:Review, Observations, and Speculations
Neurol 40:340-345, Nutt,J.G., 1990
Aspirin and Stroke
Arch Neurol 47:1353-1354, Buring,J.E.,et al, 1990
The Physician's Health Study, A Neurologist's Concern
Arch Neurol 47:1352-1354, Jonas,S., 1990
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
NEJM 323:1505-1511, 1556-15581990., Kistler,J.P.,et al, 1990
CT Enhancement After Use of Cocaine
AJNR 11:1083, Hall,A.&Wagle,V., 1990
Diphenhydramine-Induced Dystonia
Clin Pharmacy 8:471, Santora,J.,et al, 1989
Antecollis in Parkinsonism
Lancet 1:1320-1321, Jorens,P.G.,et al, 1989
Life-Threatening Cranial Dystonia Following Trihexyphenidyl Withdrawal
Movement Disorders 4:349-353, Gimenez-Roldan,S.,et al, 1989
MRI in Cockayne Syndrome Type 1
Neuroradiology 31:276-277, Boltshauser,E.,et al, 1989
Cervical Myelopathy Secondary to Movement Disorders:Case Report
Neurosurgery 24:902-905, El-Mallakh,R.S.,et al, 1989
Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989
Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Nonvalvular Atrial Fibrillation as a Cause of Fatal Massive Cerebral Infarction in the Elderly
Stroke 20:1653-1656, Yamanouchi,H.,et al, 1989
Stroke-1989 Recommendations on Stroke Prevention
Diagnosis, and Therapy, Report of the WHO Force on Stroke and CV Disorders, Stroke 20:1407-143189., , 1989